Artificial intelligence (AI) techniques offer great potential for advancing genomic medicine. The AI techniques machine learning and deep learning, a type of machine learning offer new computational approaches to streamlining key analytical problems in genomic medicine
Market Dynamics:
Rising Focus on Reducing Turnaround Time in Drug Discovery & Diagnostics, Growing Adoption of Ai-Based Solutions, and Increased Biomedical and Genomic Datasets are major factors expected to augment growth of the global artificial intelligence (ai) in genomics market over the forecast period.
For instance, in November 2020, BioMarin Pharmaceutical Inc., and Deep Genomics announced that the companies have entered into a preclinical collaboration that will use Deep Genomics artificial intelligence drug discovery platform (The AI Workbench) to identify oligonucleotide drug candidates in four rare disease indications with high unmet need.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook